Table 3 EOPC and older PDAC tumour characteristics and treatment details
From: Demographic, clinical, and pathological features of early onset pancreatic cancer patients
Tumour Characteristics | EOPC (N = 35), % (≤50 years) | PDAC (N = 334), % (> 50 years) | p value |
|---|---|---|---|
Resectable | Â | Â | 0.015 |
 Yes | 8 (22.9%) | 147 (44%) |  |
 No | 27 (77.1%) | 186 (56%) |  |
 Missing | 0 | 1 (0%) |  |
Location | Â | Â | 0.579 |
 Head/Uncinate | 27 (77%) | 265 (79%) |  |
 Body/Tail | 8 (23%) | 62 (19%) |  |
 Missing | 0 | 7 (2%) |  |
Differentiation grade | Â | Â | 0.315 |
 Well | 2 (6%) | 15 (4%) |  |
 Moderate | 16 (46%) | 127 (38%) |  |
 Poor | 12 (34%) | 170 (51%) |  |
 Missing | 5 (14%) | 22 (7%) |  |
Stages | Â | Â | 0.194 |
 I | 2 (5.8%) | 16 (5%) |  |
 II* | 6 (17.1%) | 117(34%) |  |
 III | 19 (54.2%) | 140 (42%) |  |
 IV | 8 (22.9%) | 57 (17%) |  |
 Missing | 0 | 4 (1%) |  |
Perineural invasion | Â | Â | 0.348 |
 Yes | 12 (34%) | 142 (43%) |  |
 No | 23 (66%) | 192 (57%) |  |
Perivascular invasion | |||
 Yes | 7 (20%) | 122 (37%) | 0.051 |
 No | 28 (80%) | 212 (63%) |  |
Chemotherapy/ radiotherapy | Â | Â | 0.008 |
 Yes | 21 (60%) | 153 (46%) |  |
 No | 5 (14%) | 131 (39%) |  |
 Missing | 9 (26%) | 50 (15%) |  |